# Pre-Transplant Natural Killer Cell Activity Predicts Survival and Tumor Recurrence After Living Donor Liver Transplantation

## TL;DR

Measuring natural killer cell activity before liver transplant helps predict patient survival and cancer recurrence after the procedure.

## Contribution

This study shows pre-transplant NK cell activity is an independent predictor of survival and tumor recurrence in liver transplant patients.

## Key findings

- High NK activity is linked to better overall survival in liver transplant recipients.
- High NK activity significantly improves recurrence-free survival in patients with HCC.
- NK activity is an independent factor for tumor recurrence in multivariate analysis.

## Abstract

Background/Objectives: Natural killer (NK) cells are essential mediators of innate immune defense and play a key role in tumor surveillance following liver transplantation (LT). Despite this, the prognostic relevance of pre-transplant NK cell activity in living donor LT (LDLT) has not been fully established. Methods: This retrospective analysis included 134 adult patients who underwent LDLT. NK cell activity was evaluated prior to transplantation using interferon-γ release assays and classified as low (<10 pg/mL) or high (≥10 pg/mL). Overall survival (OS) was assessed for all participants, whereas recurrence-free survival (RFS) was analyzed patients with HCC. Results: Patients classified as having high NK activity (≥10 pg/mL) experienced significantly better overall survival compared to those with low activity (log-rank p = 0.032). In the multivariate analysis, high NK activity showed a strong trend toward improved overall survival (HR, 0.52; 95% CI, 0.26–1.04; p = 0.063). Among recipients with HCC, high NK activity was associated with a markedly improved recurrence-free survival (log-rank p = 0.004). Multivariate Cox regression further established NK activity as an independent factor for tumor recurrence (HR, 0.27; 95% CI, 0.08–0.87; p = 0.028). Conclusions: Pre-transplant NK cell activity independently predicts both survival and recurrence following LDLT.